GlobeNewswire by notified

Floatgen achieves continuous capacity factor of nearly 60%

Share

BW Ideol is pleased to announce continuously strong operational results from its 5-year-old Floatgen demonstrator, showing a capacity factor of nearly 60% over the last three months and a production of 25GWh since its 2018 commissioning.

France’s first and only floating wind turbine continues to prove its reliable performance capabilities and delivered an average capacity factor of 59.2% over a 3-month period ranging from November 2022 to January 2023. The 25 GWh-milestone was reached just after the major Atlantic storm Gerard in late January. The Floatgen turbine, mounted on BW Ideol’s patented Damping Pool® foundation, handled wind speeds up to 37.30 metres per second (equivalent to 134 km/h) and up to 5.5 metres of significant wave height (equivalent to around 10.5 meters maximum wave height).

“Floatgen – one of the few floating wind turbines currently in operation across the globe – continues to deliver outstanding results in terms of reliability, efficiency and production. It keeps on validating the merits of our unique floating offshore wind technology, even in the harshest environments. Such repeated performance, high availability and consequently high capacity factor underlines the benefits of floating wind and its ability to capture the best possible wind resources without depth constraints, contributing to a much needed energy resilience in the process“ said Paul de la Guérivière, the CEO of BW Ideol.

Floatgen is a 2 MW demonstrator equipped with the world’s first concrete hull for floating offshore wind. It is operating in 33 metres water depth off the coast of Le Croisic (Western France) since 2018. It provides electricity to approximately 3,000 households. This industry-changing full-scale prototype is owned, operated and maintained by BW Ideol, generates amounts of valuable operational data and enables our own teams to develop an industry-leading hands-on expertise and track-record in terms of floating offshore wind O&M. This unique asset also serves as a full-scale and real-conditions R&D platform to qualify new components and methods as well as perform environmental impact studies.

About BW Ideol:
BW Ideol is a leading fully integrated platform in floating offshore wind with more than 12 years of experience from design, execution and development of floating wind projects based on our patented floating offshore wind technology and engineering capabilities. The company has a dual-leg growth strategy as a floater EPCI and maintenance services provider and as a wind-farm project developer and co-owner. BW Ideol has two full-scale offshore floating wind turbines in operation in France and Japan, a significant project pipeline, and is supported by BW Offshore's extensive experience from developing and operating offshore energy production systems.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. 

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Sodexo announces solid H1 Fiscal 2024 results19.4.2024 07:00:00 CEST | Press release

Issy-les-Moulineaux, April 19, 2024 Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Sodexo announces solid H1 Fiscal 2024 results Organic Revenue growth +8.5%Underlying operating profit +16.9% at constant currencies, margin up +40 bpsFiscal 2024 guidance:Organic growth now expected at the top of the +6% to +8% rangeUnderlying operating profit margin improvement confirmed at +30 to +40 bps, at constant currencies At the Board of Directors meeting held on April 18, 2024, chaired by Sophie Bellon, the Board closed the Consolidated accounts for the First half Fiscal 2024 ended February 29, 2024. First half Fiscal 2024 key figures (in million euros)H1 FISCAL 2024H1 FISCAL 2023 RESTATEDDIFFERENCEDIFFERENCE CONSTANT RATESRevenues12,10111,581 +4.5% +7.8%Organic revenue growth +8.5% +12.9%UNDERLYING OPERATING PROFIT612545+12.3%+16.9%UNDERLYING OPERATING PROFIT MARGIN5.1%4.7%+40bps+40bpsOther operating income & expenses30(36)OPERATING PROFIT642509+26.1%+30.1%Net financial expense(46)(43)Tax cha

Pluxee delivers strong performance in the First Half and raises Fiscal 2024 Organic revenue growth and Recurring EBITDA margin objectives19.4.2024 07:00:00 CEST | Press release

First Half Fiscal 2024 Results Issy-les-Moulineaux, France – April 19, 2024 First Half Fiscal 2024 highlights Successful spin-off and listing on Euronext Paris on February 1, 2024 Organic revenue growth of +24% incl. +26% in Q2, reflecting buoyant performance across all regions Strong Recurring EBITDA at €201 million, i.e. +28% organic growth; 34.4% margin at constant rates Net profit of €68 million reflecting higher one-time items, mostly spin-off related Recurring free cash flow of €228 million, with strong Recurring Cash conversion of 113%Net cash position of €1,065 million, increasing by €206 million since August 31, 2023Fiscal 2024 financial objectives raised: Organic revenue growth expected between 15% to 17% and Recurring EBITDA margin expected at 35% at least including standalone costs at constant rates, while reaffirming all mid-term targets First Half Fiscal 2024 key figures (in millions of euros)H1 FY 2024H1 FY 2023Variation (%)Variation at constant rate (%)Total revenues593

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer19.4.2024 07:00:00 CEST | Press release

Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2The National Comprehensive Cancer Network® (NCCN®) Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selection Basel, 19 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours ≥ 4 cm or node positive), as detected by an FDA-approved test. Alecensa is now the first and on

Evs Invites Its Shareholders to the Ordinary General Meeting and an Extraordinary General Meeting on May 21, 202419.4.2024 06:30:00 CEST | Press release

Publication on April 19, 2024, at 6:30 am before market opening Regulated information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS INVITES ITS SHAREHOLDERS TO THE ORDINARY GENERAL MEETING AND AN EXTRAORDINARY GENERAL MEETING ON MAY 21, 2024 EVS Broadcast Equipment, leading provider of live video production systems, published today the invitation to its Ordinary General Meeting, to be held on May 21, 2024, at 11 am, at its registered office in Liège, to deliberate on the agenda available on the website of the company (see link below). Aside from the usual topics, including the 2023 annual and sustainability reports, the Board of Directors will propose to the Shareholders to approve the following resolutions: The payment of a total gross dividend of EUR 1.10 per share (including the interim dividend of EUR 0.50 paid in November 2023);A profit-sharing plan in the form of a grant of 36 EVS shares for each EVS employee, in proportion to

Icelandic Salmon - Annual Report for 202319.4.2024 06:00:00 CEST | Press release

Bíldudalur, 19 April 2023 Icelandic Salmon AS (Euronext Growth Oslo and First North Iceland: ISLAX) has today published its integrated Annual Report for 2023, including sustainability reporting and complete annual accounts with notes. The report is attached and available on the company‘s website: https://arnarlax.is/investors/ “In 2023, Icelandic Salmon supplied the world markets with a record-breaking 17,919 tonnes of salmon, thanks to the dedicated work of our employees. Despite facing many challenges this year - including macroeconomic changes, geopolitical tensions, and biological obstacles – we prioritised the health and wellbeing of our fish. Looking ahead, we are committed to sustaining this priority while growing our operations," Bjørn Hembre, CEO of Icelandic Salmon and Arnarlax says. In Bjørn‘s letter, which in included in the report, he writes: “Salmon farming holds great promise for Iceland, in terms of future jobs and economic growth. During the past few years, we have see

HiddenA line styled icon from Orion Icon Library.Eye